Table 2 The percentages and absolute values of NK cell subsets after cytokine in vitro treatment

Controls (n = 26)

Percentage (%)

CD3 ⁻ CD56 ⁺

13.76 ± 1.75^#

14.58 ± 2.67

13.92 ± 2.66

12.47 ± 2.14

CD3 ⁻ CD56 ^dim+

12.72 ± 1.76

13.39 ± 2.64

12.04 ± 2.26

11.53 ± 2.13

CD3 ⁻ CD56 ^bright+

1.06 ± 0.11

1.18 ± 0.15

1.07 ± 0.20

0.90 ± 0.12

Apsolute values (/μl)

CD3 ⁻ CD56 ⁺

261.53 ± 19.33

280.53 ± 29.33

255.28 ± 21.38

275.14 ± 23.33

CD3 ⁻ CD56 ^dim+

250.87 ± 30.54

260.71 ± 32.55

249.39 ± 33.83

259.12 ± 35.22

CD3 ⁻ CD56 ^bright+

19.63 ± 1.39

21.13 ± 0.19

18.87 ± 0.09

20.18 ± 1.01

Patients (n = 36)

Percentage (%)

CD3 ⁻ CD56 ⁺

16.61 ± 1.99

16.82 ± 2.11

17.70 ± 2.42

17.72 ± 2.31

CD3 ⁻ CD56 ^dim+

15.56 ± 1.96

15.82 ± 2.10

16.63 ± 2.40

16.66 ± 2.29

CD3 ⁻ CD56 ^bright+

1.05 ± 0.09

1.06 ± 0.08

1.07 ± 0.10

1.03 ± 0.12

Apsolute values (/μl)

CD3 ⁻ CD56 ⁺

328.32 ± 21.33

319.83 ± 28.33

319.83 ± 25.13

338.51 ± 23.33

CD3 ⁻ CD56 ^dim+

305.13 ± 20.96

300.75 ± 39.73

321.27 ± 27.23

325.17 ± 27.71

CD3 ⁻ CD56 ^bright+

22.87 ± 0.19

25.34 ± 0.09

26.13 ± 0.33

20.01 ± 0.10